title: Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis.
authors.affiliation: Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
authors.forename: C F
authors.initials: CF
authors.lastname: Brummitt
authors.forename: J A
authors.initials: JA
authors.lastname: Porter
authors.forename: B L
authors.initials: BL
authors.lastname: Herwaldt
mesh_terms: D000967:Antimony Sodium Gluconate / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
chemical_list: D000981:Antiprotozoal Agents; D000967:Antimony Sodium Gluconate